Therapeutic plasma exchange: A technical and operational review

Journal of Clinical Apheresis

Volumn 28, Issue 1, 2013, Pages 3-10

  Kaplan, Andre A ^a,b,c  

^a University of Connecticut   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UConn Dialysis Center   (United States)

Author keywords

apheresis; plasmapheresis; therapeutic plasma exchange

Indexed keywords

ALBUMIN; DIPHENHYDRAMINE; EPHEDRINE; FRESH FROZEN PLASMA; HETASTARCH; IMMUNOGLOBULIN; PREDNISONE;

ANAPHYLAXIS; ANTICOAGULATION; CENTRIFUGATION; CONFERENCE PAPER; HEAT TREATMENT; HEMATOCRIT; HEMODILUTION; HEMOFILTRATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR SPACE; ONCOTIC PRESSURE; PARTIAL THROMBOPLASTIN TIME; PLASMA VOLUME; PLASMAPHERESIS; PRACTICE GUIDELINE; THERAPEUTIC PLASMA EXCHANGE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ALGORITHMS; ANTICOAGULANTS; BLOOD VOLUME; ELECTROLYTES; FILTRATION; HUMANS; IMMUNOGLOBULINS; MACROMOLECULAR SUBSTANCES; OSMOLAR CONCENTRATION; PLASMA; PLASMA EXCHANGE; SERUM ALBUMIN;

EID: 84874085682     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21257     Document Type: Conference Paper

References (65)

1. Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK,. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979; 300: 524-530.
2. Schroeder JO, Euler HH, Loffler H,. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 1987; 107: 344-346.
3. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA,. Comparison of plasma exchange with plasma infusion in the treatment of TTP. N Eng J Med 1991; 325: 393-397.
4. Cohen S, Freeman T,. Metabolic heterogeneity of human gamma globulin. Biochem J 1960; 76: 475-487.
5. Kaplan AA,. A simple and accurate method for prescribing plasma exchange. Trans Am Soc Artif Intern Organs 1990; 36: M597-M599.
6. Inkley SR, Brooks L, Krieger H,. A study of methods for the prediction of plasma volume. J Lab Clin Med 1955; 45: 841-850.
7. Retzlaff JA, Newlon Tauxe W, Kiely JM, Stroebel CF,. Erythrocyte volume, plasma volume and lean body mass in adult men and women. Blood 1969; 33: 649-667.
8. Feldschuh J, Enson Y,. Prediction of the normal blood volume: relation of blood volume to body habitus. Circulation 1977; 56: 605-612.
9. Sprenger KBG, Huber K, Kratz, Henze E, Franz HE,. Prediction of patients plasma volume in plasma exchange therapy. In:, Smeby LC, Jorstad S, Wideroe TE, editors. Immune and Metabolic Aspects of therapeutic Blood Purification Systems. Basel, Switzerland: Karger. 1986. pp 394-402.
10. Kaplan AA, Halley SE,. Plasma exchange with a rotating filter. Kidney Int 1990; 38: 160-166.
11. Chopek M, McCullough J,. Protein and biochemical changes during plasma exchange. In:, Ulmas J,., Berkman E, editors. Therapeutic Hemapheresis: A Technical Workshop. Washington, DC: American Association of Blood Banks, 1980. pp 13-52.
12. Morgenthaler JJ, Nydegger UE,. Synthesis, distribution and catabolism of human plasma proteins in plasma exchange. Int J Artif Organs 1984; 7: 27-34.
13. Thornton CA, Griggs RC,. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35: 260-268.
14. Bowman BH,. Hepatic Plasma Proteins: Mechanisms of Function and Regulation. San Diego: Academic Press, Inc., Harcourt Brace Jovanovich, 1993.
15. Herbert LA,. The clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 1991; 27: 352-361.
16. Barth WF, Wochner D, Waldmann TA, Fahey JL,. Metabolism of human gamma macroglobulins. J Clin Invest 1964; 43: 1036-1048.
17. Russell, JA, Fitzharris, BM, Corringham, R, Darcy DA, Powles RL,. Plasma exchange v peritoneal dialysis for removing Bence Jones protein. Br Med J 1978; 2: 1397.
18. Fisher Jr, CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E,. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996; 334: 1697-1702.
19. May ME, Mintz PD, Gray LS,. Multicompartment analysis of the effects of plasmapheresis: application to lipid kinetics in humans. Am J Clin Pathol 1989; 91: 688-694.
20. Carter PW, Cohen HJ, Crawford J,. Hyperviscosity syndrome in association with kappa light chain myeloma. Am J Med 1989; 86: 591-601.
21. Misiani R, Tiraboschi G, Mingardi G, Mecca G,. Management of myeloma kidney: an anti-light chain approach. Am J Kidney Dis 1987; 10: 28-33.
22. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P,. Removal of pro inflammatory cytokines with renal replacement therapy: sense or non-sense? Intensive Care Med 1995; 21: 169-176.
23. Kaplan AA,. Towards a rational prescription of plasma exchange: the kinetics of immunoglobulin removal. Semin Dial 1992; 5: 227-229.
24. Roberts CG, Schindhelm K, Smeby LC, Farrell PC,. Kinetic analysis of plasma separation: use of an animal model. In:, Lysaght MJ, Gurland HJ, editors. Plasma Separation and Plasma Fractionation. Basel, Switzerland: Karger, 1983. pp 25-38.
25. Charlton B, Schindhelm K, Farrell PC,. Effect of extracorporeal IgG removal on IgG kinetics. Trans Am Soc Artif Intern Organs 1983; 29: 724-729.
26. Kellogg RM, Hester JP,. Kinetics modeling of plasma exchange: intra and post-plasma exchange. J Clin Apheresis 1988; 4: 183-187.
27. Keller AJ, Urbaniak SJ,. Intensive plasma exchange on the cell separator: effects on serum immunoglobulins and complement components. Br J Haematol 1978; 38: 531-540.
28. Swainson P, Robson JS, Urbaniak SJ, Keller AJ, Kay AB,. Treatment of Goodpasture's disease by plasma exchange and immunosuppression. Clin Exp Immunol 1978; 32: 233-242.
29. Jones JV, Robinson MF, Parciany RK, Layfer LF, McLeod B,. Therapeutic plasmapheresis in systemic lupus erythematosus: effect on immune complexes and antibodies to DNA. Arthritis Rheum 1981; 24: 1113-1120.
30. Gurland HJ, Lysaght MH, Samtleben W, Schmidt B,. A comparison of centrifugal and membrane based apheresis formats. Int J Artif Organs 1984; 7: 35-38.
31. Gurland HJ, Lysaght MJ, Samtleben W, Schmidt B,. Comparative evaluation of filters used in membrane plasmapheresis. Nephron 1984; 36: 173-182.
32. Sowada K, Malchesky PS, Nose Y,. Available removal systems: state of the art. In:, Nydegger UE, editor. Therapeutic Hemapheresis in the 1990s. Current Studies in Hematology and Blood Transfusion, Vol. 57. Basel, Switzerland: Karger. 1990. pp 51-113.
33. Ilamathi E, Kirsch M, Moore B, Finger M,. Citrate anticoagulation during plasmapheresis using standard hemodialysis equipment. Semin Dial 1993; 6: 268.
34. Mokrzycki MH, Kaplan AA,. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994; 23: 817-827.
35. Olson PR, Cox C, McCullough J,. Laboratory and clinical effects of the infusion of ACD solution during platelet-pheresis. Vox Sang 1977; 33: 79-87.
36. Hester JP, McCullough J, Mishler JM, Szymanski IO,. Dosage regimens for citrate anticoagulants. J Clin Apheresis 1983; 1: 149-157.
37. Lasky LC, Finnerty EP, Genis L, Polesky HF,. Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange. Transfusion 1984; 24: 256-259.
38. McLeod BC, Sassetti RJ, Stefoski D, Davis FA,. Partial plasma protein replacement in therapeutic plasma exchange. J Clin Apheresis 1983; 1: 115-118.
39. Finlayson JS,. Albumin products. Semin Thromb Hemost 1980; 6: 85-120.
40. Mousson C, Charhon SA, Ammar M, Accominotti M, Rifle G,. Aluminum bone deposits in normal renal function patients after long-term treatment by plasma exchange. Int J Artif Organs 1989; 23: 664-667.
41. Milliner DS, Shinaberger JH, Shurman P, Coburn JW,: Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin replacement solutions. N Engl J Med 1985; 312: 165-167.
42. Apter AJ, Kaplan AA,. An approach to immunologic reactions with plasma exchange. J Allergy Clin Immunol 1992; 90: 119-124.
43. Stafford CT, Lobel SA, Fruge BC, Moffitt JE, Hoff RG, Fadel HE,. Anaphylaxis to human serum albumin. Ann Allergy 1988; 61: 85-88.
44. Brecher ME, Owen Hg, Collins ML,. Apheresis and ACE inhibitors (letter). Transfusion 1993; 33: 963-964.
45. Owen HG, Brecher ME,. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 1994; 34: 891-894.
46. Kaplan AA, Halley SE,. Plasma exchange with a rotating filter. Kidney Int 1990; 38: 160-166.
47. Chrinside A, Urbaniak SJ, Prowse CV, Keller AJ,. Coagulation abnormalities following intensive plasma exchange on the cell separator. Br J Haematol 1981; 48: 627-634.
48. Kaplan AA,. Towards a rational prescription of plasma exchange: the kinetics of immunoglobulin removal (editorial). Semin Dial 1992; 5: 227-229.
49. Sultan Y, Bussel A, Maisonneuve P, Sitty X, Gajdos P,. Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion 1979; 19: 588-593.
50. Haas A,. Use of intravenous immunoglobulin in immunoregulatory disorders. In: Stiehm ER, moderator, editor. Intravenous Immunoglobulins as Therapeutic Agents. Ann Intern Med 1987; 107: 367-382.
51. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T,. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607-1611.
52. Schiff RI,. Transmission of viral infections through intravenous immune globulin (editorial). N Eng J Med 1994; 331: 1649-1650.
53. Ring J, Messmer K,. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-469.
54. Bambauer R, Jutzler GA, Albrecht D, Keller HE, Kohler M,. Indications of plasmapheresis and selection of different substitution solutions. Biomater Artif Cells Artif Organs 1989; 17: 9-27.
55. Huestis DW,. Mortality in therapeutic haemapheresis (letter). Lancet 1983; 1: 1043.
56. Aufeuvre JP, Morin-Hertel F, Cohen-Solal M, Lefloch A, Baudelot J,. Hazards of plasma exchange. In: Sieberth HG, editor. Plasma Exchange. Stuttgart, Germany: FK Schattauer. 1980 pp 149-157.
57. Aufeuvre JP, Mortin-Hertel F, Cohen-Solal M, Lefloch A, Baudelot J,. Clinical tolerance and hazards of plasma exchanges: a study of 6200 plasma exchanges in 1033 patients. In:, Beyer JH, Burgerg H, Fuchs C, Nagel GA, editors. Plasmapheresis in Immunology and Oncology. Basel, Switzerland: Karger. 1982. pp 65-77.
58. Sutton DMC, Nair R, Rock G, and the Canadian Apheresis Study Group. Complications of plasma exchange. Transfusion 1989; 29: 124-127.
59. Pearl RG, Rosenthal MH,. Metabolic alkalosis due to plasmapheresis. Am J Med 1985; 79: 391-393.
60. Stramer SLGlynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP,; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351: 760-768.
61. Stramer SL,. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007; 31: 702-707.
62. Dwyre DM, Fernando LP, Holland PV,. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sanguinis 2011; 100: 92-98.
63. Brecher ME, Owen HG, Bandarenko N,. Alternatives to albumin: starch replacement for plasma exchange. J Clin Apheresis 1997; 12: 146-153.
64. Owen HG, Brecher ME,. Partial colloid starch replacement for therapeutic plasma exchange. J Clin Apheresis 1997; 12: 87-92.
65. Brecher ME, Owen HG,. Washout kinetics of colloid starch as a partial or full replacement for plasma exchange. J Clin Apheresis 1996; 11: 123-126.